1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22295
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGeorgopoulou, A. P.en
dc.contributor.authorSavva, A.en
dc.contributor.authorGiamarellos-Bourboulis, E. J.en
dc.contributor.authorGeorgitsi, M.en
dc.contributor.authorRaftogiannis, M.en
dc.contributor.authorAntonakos, N.en
dc.contributor.authorApostolidou, E.en
dc.contributor.authorCarrer, D. P.en
dc.contributor.authorDimopoulos, G.en
dc.contributor.authorEconomou, A.en
dc.contributor.authorEfthymiou, G.en
dc.contributor.authorGalanakis, N.en
dc.contributor.authorGalani, L.en
dc.contributor.authorGargalianos, P.en
dc.contributor.authorKaraiskos, I.en
dc.contributor.authorKatsenos, C.en
dc.contributor.authorKavatha, D.en
dc.contributor.authorKoratzanis, E.en
dc.contributor.authorLabropoulos, P.en
dc.contributor.authorLada, M.en
dc.contributor.authorNakos, G.en
dc.contributor.authorPaggalou, E.en
dc.contributor.authorPanoutsopoulos, G.en
dc.contributor.authorParaschos, M.en
dc.contributor.authorPavleas, I.en
dc.contributor.authorPontikis, K.en
dc.contributor.authorPoulakou, G.en
dc.contributor.authorPrekates, A.en
dc.contributor.authorSybardi, S.en
dc.contributor.authorTheodorakopoulou, M.en
dc.contributor.authorTrakatelli, C.en
dc.contributor.authorTsiaoussis, P.en
dc.contributor.authorGogos, C.en
dc.contributor.authorGiamarellou, H.en
dc.contributor.authorArmaganidis, A.en
dc.contributor.authorMeisner, M.en
dc.date.accessioned2015-11-24T19:23:23Z-
dc.date.available2015-11-24T19:23:23Z-
dc.identifier.issn1557-8615-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22295-
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAnti-Infective Agents/*therapeutic useen
dc.subjectBiological Markers/blooden
dc.subjectCalcitonin/*blooden
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectOdds Ratioen
dc.subjectPractice Guidelines as Topicen
dc.subjectPrognosisen
dc.subjectProspective Studiesen
dc.subjectProtein Precursors/*blooden
dc.subjectSepsis/*blood/*drug therapy/mortalityen
dc.subjectTime Factorsen
dc.subjectTreatment Outcomeen
dc.titleEarly changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsisen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1016/j.jcrc.2010.07.012-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20869839-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0883944110001905/1-s2.0-S0883944110001905-main.pdf?_tid=55266b6655c201c0cbbfc3dfb50e6cdb&acdnat=1333608462_ef855e5e25a4e8826ac5bf6eee01dc38-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2011-
heal.abstractPURPOSE: The objective of this study is to define if early changes of procalcitonin (PCT) may inform about prognosis and appropriateness of administered therapy in sepsis. METHODS: A prospective multicenter observational study was conducted in 289 patients. Blood samples were drawn on day 1, that is, within less than 24 hours from advent of signs of sepsis, and on days 3, 7, and 10. Procalcitonin was estimated in serum by the ultrasensitive Kryptor assay (BRAHMS GmbH, Hennigsdorf, Germany). Patients were divided into the following 2 groups according to the type of change of PCT: group 1, where PCT on day 3 was decreased by more than 30% or was below 0.25 ng/mL, and group 2, where PCT on day 3 was either increased above 0.25 ng/mL or decreased less than 30%. RESULTS: Death occurred in 12.3% of patients of group 1 and in 29.9% of those of group 2 (P < .0001). Odds ratio for death of patients of group 1 was 0.328. Odds ratio for the administration of inappropriate antimicrobials of patients of group 2 was 2.519 (P = .003). CONCLUSIONS: Changes of serum PCT within the first 48 hours reflect the benefit or not of the administered antimicrobial therapy. Serial PCT measurements should be used in clinical practice to guide administration of appropriate antimicrobials.en
heal.journalNameJ Crit Careen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Georgopoulou-2011-Early changes of pro.pdf278.36 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons